NCT06622265Completed
WHOOP ECG Software Performance Assessment Study
Multi-phase, Prospective, Multicenter, Non-interventional, Pre-market, Non-randomized, Open-label Study to Evaluate the Clinical Performance of the WHOOP ECG Feature
Source: ClinicalTrials.gov · Last updated 2 Oct 2024
Brief summary (registry, in English)
The purpose of the study is to evaluate the performance of ECG classification algorithms and their ability to classify heart rhythms into multiple categories of rhythms and heart rates.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 540 (actual)
- First submitted
- 24 Sept 2024
- Start date
- 15 May 2024
- Primary completion date
- 3 Jul 2024
- Lead sponsor
- Whoop Inc.
- Diseases
- Atrial fibrillation
- NCT number
- NCT06622265
What you commit to
- Study type: Observational
- Participants enrolled: 540
- From 15 May 2024 to the primary completion date, 3 Jul 2024
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Medical history of a life-threatening cardiac arrhythmia, e.g., ventricular tachycardia or fibrillation.
- Any known allergies to medical adhesives, isopropyl alcohol, or ECG patch.
- Any known allergy or sensitivity to thermoplastics, metals with physical vapor deposition (PVD) coatings or Elastane used in the wrist fitness devices.
- Mental impairment as determined by the Investigator, or designee.
- Subjects with any medical history, physical examination finding, vital sign or other finding or assessment that could compromise subject safety, study integrity or accurate assessment of study objectives. This includes, but is not limited to, known untreated medical conditions that may be considered clinically significant, such as significant anemia, electrolyte imbalance, untreated or uncontrolled thyroid disease, and open wound(s) in the area of test band positioning.
- Severe skin conditions on either wrist, that would preclude wearing the sensor. Severe symptomatic skin injury, disorder, allergy, or disease such as eczema, rosacea, impetigo, dermatomyositis or contact dermatitis on wrist or other areas where sensors or electrodes would be placed.
Other
- -Subjects with an implantable pacemaker device or implantable cardioverter- defibrillator device.
- Clinically significant body tremors that compromise study measurements.
- Pregnant at the time of enrollment.
- Any physical disability that prevents safe and adequate testing.
- Physical or medical impairments that preclude exercise testing, including, but not limited to, back pain and leg claudication.
- Vital sign measurements, medical history or physical examination finding that makes the subject inappropriate for participation according to the Investigator.
- Scarring, tattoos, large, pigmented moles, or other skin pathology in the area of sensor location.
- Clinically significant hand tremors as judged by the Investigator.
- Participated in phase 1 of the study (Only for phase 2 cohort).
Who the study is looking for
- Aged 22 years or older.
- Ability to provide informed consent.
- Willing to participate and to follow the procedures per the Principal Investigator's instructions.
- Resided in the United States.
- Wrist circumference: 130 mm to 245 mm at band wear position.
- Previous medical history of persistent, paroxysmal, or permanent or chronic AF and being in AF at time of enrollment (AF cohort only).
- No known history of AF and being in normal sinus rhythm at the time of enrollment (NSR cohort only).
Age in the registry: 22 years to - · Sex: All · Accepts healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Valley Clinical Trials Coordinator of this site? Confirm its status | Covina | United States | Unknown status |
| IQVIA Coordinator of this site? Confirm its status | Lenexa | United States | Unknown status |
| Valley Clinical Trials Coordinator of this site? Confirm its status | Northridge | United States | Unknown status |
| Hope Research Institute Coordinator of this site? Confirm its status | Phoenix | United States | Unknown status |
| Eximia Research - NC, LLC Coordinator of this site? Confirm its status | Raleigh | United States | Unknown status |
| Fairview Frontiers Coordinator of this site? Confirm its status | Saint Paul | United States | Unknown status |
| Flourish Research Coordinator of this site? Confirm its status | Winter Park | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.